Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

EU implements plan to prevent falsified medicines

Jaclyn Jaeger | February 17, 2016

The European Medicines Agency and the European Commission last week announced a plan to prevent falsified medicines from entering the market.

The European Medicines Agency (EMA) defines falsified medicines as “fake medicines that pass themselves off as real, authorized medicines.” In July 2011, the EU strengthened the protection of patients and consumers by adopting the Falsified Medicines Directive (Directive 2011/62/EU), whose purpose is to not only prevent falsified medicines from entering the supply chain, but also to allow EU citizens to buy high-quality medicines online through verified sources. It introduces harmonized safety and strengthened control measures across Europe by applying new safety measures.


Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.